載入...
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies
Cutaneous lupus erythematosus (CLE) is an autoimmune disease of the skin with significant morbidity. Current treatments are often inadequate to control disease and there are no Food and Drug Administration (FDA)-approved therapies for this potentially debilitating disease, underscoring an unmet medi...
Na minha lista:
| 發表在: | Yale J Biol Med |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
YJBM
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087060/ https://ncbi.nlm.nih.gov/pubmed/32226339 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|